BIFIDO（A238200）株式概要株式会社BIFIDOは、プロバイオティクスをベースとした製品を韓国内外で製造している。 詳細A238200 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性4/6配当金0/6リスク分析過去5年間で収益は年間62%減少しました。 意味のある時価総額がありません ( ₩23B )すべてのリスクチェックを見るA238200 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₩Current Price₩2.80k35.8% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-5b29b2016201920222025202620282031Revenue ₩28.9bEarnings ₩2.8bAdvancedSet Fair ValueView all narrativesBIFIDO Co., Ltd. 競合他社Sewha P&CSymbol: KOSDAQ:A252500Market cap: ₩32.5bOutin FuturesSymbol: KOSDAQ:A227610Market cap: ₩30.1bBonneSymbol: KOSDAQ:A226340Market cap: ₩27.1bHurumSymbol: KOSDAQ:A353190Market cap: ₩22.2b価格と性能株価の高値、安値、推移の概要BIFIDO過去の株価現在の株価₩2,795.0052週高値₩4,390.0052週安値₩2,460.00ベータ0.901ヶ月の変化-4.77%3ヶ月変化-0.71%1年変化-22.68%3年間の変化-64.03%5年間の変化-73.38%IPOからの変化-84.68%最新ニュースReported Earnings • Mar 17Full year 2025 earnings released: ₩24.00 loss per share (vs ₩660 loss in FY 2024)Full year 2025 results: ₩24.00 loss per share (improved from ₩660 loss in FY 2024). Revenue: ₩19.7b (up 59% from FY 2024). Net loss: ₩192.7m (loss narrowed 96% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 43 percentage points per year, which is a significant difference in performance.お知らせ • Feb 25BIFIDO Co., Ltd., Annual General Meeting, Mar 19, 2026BIFIDO Co., Ltd., Annual General Meeting, Mar 19, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 23-16, nonggongdanji-gil, hongcheon-eup, hongcheon-gun, gangwon-do, South Korea分析記事 • Oct 17Some Confidence Is Lacking In BIFIDO Co., Ltd.'s (KOSDAQ:238200) P/SBIFIDO Co., Ltd.'s ( KOSDAQ:238200 ) price-to-sales (or "P/S") ratio of 1.7x may not look like an appealing investment...分析記事 • Aug 18Is BIFIDO (KOSDAQ:238200) A Risky Investment?KOSDAQ:A238200 1 Year Share Price vs Fair Value Explore BIFIDO's Fair Values from the Community and select yours Howard...分析記事 • May 22BIFIDO Co., Ltd.'s (KOSDAQ:238200) Shares May Have Run Too Fast Too SoonWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...Reported Earnings • Mar 15Full year 2024 earnings released: ₩660 loss per share (vs ₩132 profit in FY 2023)Full year 2024 results: ₩660 loss per share (down from ₩132 profit in FY 2023). Revenue: ₩12.4b (down 34% from FY 2023). Net loss: ₩5.40b (down ₩6.48b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.最新情報をもっと見るRecent updatesReported Earnings • Mar 17Full year 2025 earnings released: ₩24.00 loss per share (vs ₩660 loss in FY 2024)Full year 2025 results: ₩24.00 loss per share (improved from ₩660 loss in FY 2024). Revenue: ₩19.7b (up 59% from FY 2024). Net loss: ₩192.7m (loss narrowed 96% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 43 percentage points per year, which is a significant difference in performance.お知らせ • Feb 25BIFIDO Co., Ltd., Annual General Meeting, Mar 19, 2026BIFIDO Co., Ltd., Annual General Meeting, Mar 19, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 23-16, nonggongdanji-gil, hongcheon-eup, hongcheon-gun, gangwon-do, South Korea分析記事 • Oct 17Some Confidence Is Lacking In BIFIDO Co., Ltd.'s (KOSDAQ:238200) P/SBIFIDO Co., Ltd.'s ( KOSDAQ:238200 ) price-to-sales (or "P/S") ratio of 1.7x may not look like an appealing investment...分析記事 • Aug 18Is BIFIDO (KOSDAQ:238200) A Risky Investment?KOSDAQ:A238200 1 Year Share Price vs Fair Value Explore BIFIDO's Fair Values from the Community and select yours Howard...分析記事 • May 22BIFIDO Co., Ltd.'s (KOSDAQ:238200) Shares May Have Run Too Fast Too SoonWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...Reported Earnings • Mar 15Full year 2024 earnings released: ₩660 loss per share (vs ₩132 profit in FY 2023)Full year 2024 results: ₩660 loss per share (down from ₩132 profit in FY 2023). Revenue: ₩12.4b (down 34% from FY 2023). Net loss: ₩5.40b (down ₩6.48b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.お知らせ • Feb 27BIFIDO Co., Ltd., Annual General Meeting, Mar 20, 2025BIFIDO Co., Ltd., Annual General Meeting, Mar 20, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 23-16, nonggongdanji-gil, hongcheon-eup, hongcheon-gun, gangwon-do, South KoreaNew Risk • Dec 16New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩25.8b market cap, or US$17.9m).分析記事 • Oct 29BIFIDO Co., Ltd.'s (KOSDAQ:238200) Business Is Yet to Catch Up With Its Share PriceWhen close to half the companies in the Personal Products industry in Korea have price-to-sales ratios (or "P/S") below...分析記事 • Jun 27Is BIFIDO (KOSDAQ:238200) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Valuation Update With 7 Day Price Move • Mar 26Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩6,480, the stock trades at a trailing P/E ratio of 49x. Average trailing P/E is 29x in the Personal Products industry in South Korea. Total loss to shareholders of 50% over the past three years.分析記事 • Mar 25BIFIDO Co., Ltd's (KOSDAQ:238200) 31% Price Boost Is Out Of Tune With EarningsBIFIDO Co., Ltd ( KOSDAQ:238200 ) shareholders have had their patience rewarded with a 31% share price jump in the last...Reported Earnings • Mar 22Full year 2023 earnings released: EPS: ₩132 (vs ₩189 in FY 2022)Full year 2023 results: EPS: ₩132 (down from ₩189 in FY 2022). Revenue: ₩18.6b (up 28% from FY 2022). Net income: ₩1.08b (down 30% from FY 2022). Profit margin: 5.8% (down from 11% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.New Risk • Nov 30New major risk - Revenue and earnings growthEarnings have declined by 9.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.4% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.8% net profit margin). Market cap is less than US$100m (₩42.9b market cap, or US$33.1m).お知らせ • Oct 06BIFIDO Co., Ltd announced that it has received KRW 15 billion in fundingOn October 4, 2023, BIFIDO Co., Ltd closed the transaction.New Risk • Aug 31New major risk - Revenue and earnings growthEarnings have declined by 4.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.5% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩54.8b market cap, or US$41.4m).Reported Earnings • Mar 19Full year 2022 earnings released: EPS: ₩189 (vs ₩551 in FY 2021)Full year 2022 results: EPS: ₩189 (down from ₩551 in FY 2021). Revenue: ₩14.6b (up 20% from FY 2021). Net income: ₩1.55b (down 66% from FY 2021). Profit margin: 11% (down from 37% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 4% per year and the company’s share price has also increased by 4% per year.Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improved over the past weekAfter last week's 38% share price gain to ₩10,150, the stock trades at a trailing P/E ratio of 73.5x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years.Valuation Update With 7 Day Price Move • May 18Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩10,100, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 16x in the Personal Products industry in South Korea. Total loss to shareholders of 36% over the past three years.Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₩551 (up from ₩68.00 loss in FY 2020). Revenue: ₩12.1b (down 2.1% from FY 2020). Net income: ₩4.49b (up ₩5.05b from FY 2020). Profit margin: 37% (up from net loss in FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Oct 06Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩10,600, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 25x in the Personal Products industry in South Korea. Negligible returns to shareholders over past year.Valuation Update With 7 Day Price Move • Aug 19Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩13,900, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 30x in the Personal Products industry in South Korea. Total returns to shareholders of 68% over the past year.Valuation Update With 7 Day Price Move • Jul 27Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩14,800, the stock trades at a trailing P/E ratio of 25.1x. Average trailing P/E is 36x in the Personal Products industry in South Korea. Total returns to shareholders of 62% over the past year.Valuation Update With 7 Day Price Move • Jul 06Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩16,750, the stock trades at a trailing P/E ratio of 28.4x. Average trailing P/E is 34x in the Personal Products industry in South Korea. Total returns to shareholders of 71% over the past year.Valuation Update With 7 Day Price Move • Jun 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩13,300, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 31x in the Personal Products industry in South Korea. Total returns to shareholders of 29% over the past year.Is New 90 Day High Low • Mar 15New 90-day high: ₩27,750The company is up 40% from a price of ₩19,800 on 15 December 2020. Outperformed the South Korean market which is up 9.0% over the last 90 days. Exceeded the Personal Products industry, which is up 5.0% over the same period.分析記事 • Mar 10The BIFIDO (KOSDAQ:238200) Share Price Is Up 31% And Shareholders Are Holding OnWe believe investing is smart because history shows that stock markets go higher in the long term. But not every stock...Is New 90 Day High Low • Dec 16New 90-day high: ₩21,350The company is up 17% from its price of ₩18,250 on 17 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 8.0% over the same period.分析記事 • Nov 25BIFIDO's (KOSDAQ:238200) Shareholders Are Down 25% On Their SharesPassive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active...Is New 90 Day High Low • Oct 05New 90-day high: ₩20,100The company is up 3.0% from its price of ₩19,600 on 07 July 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Personal Products industry, which is also up 3.0% over the same period.株主還元A238200KR Personal ProductsKR 市場7D-9.7%-2.9%4.6%1Y-22.7%27.4%186.7%株主還元を見る業界別リターン: A238200過去 1 年間で27.4 % の収益を上げたKR Personal Products業界を下回りました。リターン対市場: A238200は、過去 1 年間で186.7 % のリターンを上げたKR市場を下回りました。価格変動Is A238200's price volatile compared to industry and market?A238200 volatilityA238200 Average Weekly Movement6.1%Personal Products Industry Average Movement8.7%Market Average Movement9.4%10% most volatile stocks in KR Market16.6%10% least volatile stocks in KR Market4.9%安定した株価: A238200 、 KR市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: A238200の 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト199983Myeongsoo Parkwww.bifido.comLtd.はプロバイオティクスをベースとした製品を韓国内外で製造している。同社は、免疫調整用のBGN4、乳児のロタウイルス感染症の治療に使用されるBORI、一般的な腸の健康問題用のAD011などのビフィズス菌株製品を提供している。同社は1999年に設立され、韓国の洪川邑に本社を置いている。もっと見るBIFIDO Co., Ltd. 基礎のまとめBIFIDO の収益と売上を時価総額と比較するとどうか。A238200 基礎統計学時価総額₩22.86b収益（TTM）-₩192.74m売上高(TTM)₩19.68b1.2xP/Sレシオ-118.6xPER（株価収益率A238200 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計A238200 損益計算書（TTM）収益₩19.68b売上原価₩12.19b売上総利益₩7.49bその他の費用₩7.68b収益-₩192.74m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-23.56グロス・マージン38.06%純利益率-0.98%有利子負債／自己資本比率26.1%A238200 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 04:01終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BIFIDO Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Mar 17Full year 2025 earnings released: ₩24.00 loss per share (vs ₩660 loss in FY 2024)Full year 2025 results: ₩24.00 loss per share (improved from ₩660 loss in FY 2024). Revenue: ₩19.7b (up 59% from FY 2024). Net loss: ₩192.7m (loss narrowed 96% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 43 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 25BIFIDO Co., Ltd., Annual General Meeting, Mar 19, 2026BIFIDO Co., Ltd., Annual General Meeting, Mar 19, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 23-16, nonggongdanji-gil, hongcheon-eup, hongcheon-gun, gangwon-do, South Korea
分析記事 • Oct 17Some Confidence Is Lacking In BIFIDO Co., Ltd.'s (KOSDAQ:238200) P/SBIFIDO Co., Ltd.'s ( KOSDAQ:238200 ) price-to-sales (or "P/S") ratio of 1.7x may not look like an appealing investment...
分析記事 • Aug 18Is BIFIDO (KOSDAQ:238200) A Risky Investment?KOSDAQ:A238200 1 Year Share Price vs Fair Value Explore BIFIDO's Fair Values from the Community and select yours Howard...
分析記事 • May 22BIFIDO Co., Ltd.'s (KOSDAQ:238200) Shares May Have Run Too Fast Too SoonWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...
Reported Earnings • Mar 15Full year 2024 earnings released: ₩660 loss per share (vs ₩132 profit in FY 2023)Full year 2024 results: ₩660 loss per share (down from ₩132 profit in FY 2023). Revenue: ₩12.4b (down 34% from FY 2023). Net loss: ₩5.40b (down ₩6.48b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 17Full year 2025 earnings released: ₩24.00 loss per share (vs ₩660 loss in FY 2024)Full year 2025 results: ₩24.00 loss per share (improved from ₩660 loss in FY 2024). Revenue: ₩19.7b (up 59% from FY 2024). Net loss: ₩192.7m (loss narrowed 96% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 43 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 25BIFIDO Co., Ltd., Annual General Meeting, Mar 19, 2026BIFIDO Co., Ltd., Annual General Meeting, Mar 19, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 23-16, nonggongdanji-gil, hongcheon-eup, hongcheon-gun, gangwon-do, South Korea
分析記事 • Oct 17Some Confidence Is Lacking In BIFIDO Co., Ltd.'s (KOSDAQ:238200) P/SBIFIDO Co., Ltd.'s ( KOSDAQ:238200 ) price-to-sales (or "P/S") ratio of 1.7x may not look like an appealing investment...
分析記事 • Aug 18Is BIFIDO (KOSDAQ:238200) A Risky Investment?KOSDAQ:A238200 1 Year Share Price vs Fair Value Explore BIFIDO's Fair Values from the Community and select yours Howard...
分析記事 • May 22BIFIDO Co., Ltd.'s (KOSDAQ:238200) Shares May Have Run Too Fast Too SoonWhen you see that almost half of the companies in the Personal Products industry in Korea have price-to-sales ratios...
Reported Earnings • Mar 15Full year 2024 earnings released: ₩660 loss per share (vs ₩132 profit in FY 2023)Full year 2024 results: ₩660 loss per share (down from ₩132 profit in FY 2023). Revenue: ₩12.4b (down 34% from FY 2023). Net loss: ₩5.40b (down ₩6.48b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 27BIFIDO Co., Ltd., Annual General Meeting, Mar 20, 2025BIFIDO Co., Ltd., Annual General Meeting, Mar 20, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 23-16, nonggongdanji-gil, hongcheon-eup, hongcheon-gun, gangwon-do, South Korea
New Risk • Dec 16New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩25.8b market cap, or US$17.9m).
分析記事 • Oct 29BIFIDO Co., Ltd.'s (KOSDAQ:238200) Business Is Yet to Catch Up With Its Share PriceWhen close to half the companies in the Personal Products industry in Korea have price-to-sales ratios (or "P/S") below...
分析記事 • Jun 27Is BIFIDO (KOSDAQ:238200) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Valuation Update With 7 Day Price Move • Mar 26Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩6,480, the stock trades at a trailing P/E ratio of 49x. Average trailing P/E is 29x in the Personal Products industry in South Korea. Total loss to shareholders of 50% over the past three years.
分析記事 • Mar 25BIFIDO Co., Ltd's (KOSDAQ:238200) 31% Price Boost Is Out Of Tune With EarningsBIFIDO Co., Ltd ( KOSDAQ:238200 ) shareholders have had their patience rewarded with a 31% share price jump in the last...
Reported Earnings • Mar 22Full year 2023 earnings released: EPS: ₩132 (vs ₩189 in FY 2022)Full year 2023 results: EPS: ₩132 (down from ₩189 in FY 2022). Revenue: ₩18.6b (up 28% from FY 2022). Net income: ₩1.08b (down 30% from FY 2022). Profit margin: 5.8% (down from 11% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.
New Risk • Nov 30New major risk - Revenue and earnings growthEarnings have declined by 9.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.4% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.8% net profit margin). Market cap is less than US$100m (₩42.9b market cap, or US$33.1m).
お知らせ • Oct 06BIFIDO Co., Ltd announced that it has received KRW 15 billion in fundingOn October 4, 2023, BIFIDO Co., Ltd closed the transaction.
New Risk • Aug 31New major risk - Revenue and earnings growthEarnings have declined by 4.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.5% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩54.8b market cap, or US$41.4m).
Reported Earnings • Mar 19Full year 2022 earnings released: EPS: ₩189 (vs ₩551 in FY 2021)Full year 2022 results: EPS: ₩189 (down from ₩551 in FY 2021). Revenue: ₩14.6b (up 20% from FY 2021). Net income: ₩1.55b (down 66% from FY 2021). Profit margin: 11% (down from 37% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 4% per year and the company’s share price has also increased by 4% per year.
Valuation Update With 7 Day Price Move • Dec 02Investor sentiment improved over the past weekAfter last week's 38% share price gain to ₩10,150, the stock trades at a trailing P/E ratio of 73.5x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years.
Valuation Update With 7 Day Price Move • May 18Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩10,100, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 16x in the Personal Products industry in South Korea. Total loss to shareholders of 36% over the past three years.
Reported Earnings • Mar 18Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: ₩551 (up from ₩68.00 loss in FY 2020). Revenue: ₩12.1b (down 2.1% from FY 2020). Net income: ₩4.49b (up ₩5.05b from FY 2020). Profit margin: 37% (up from net loss in FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Oct 06Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩10,600, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 25x in the Personal Products industry in South Korea. Negligible returns to shareholders over past year.
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩13,900, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 30x in the Personal Products industry in South Korea. Total returns to shareholders of 68% over the past year.
Valuation Update With 7 Day Price Move • Jul 27Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩14,800, the stock trades at a trailing P/E ratio of 25.1x. Average trailing P/E is 36x in the Personal Products industry in South Korea. Total returns to shareholders of 62% over the past year.
Valuation Update With 7 Day Price Move • Jul 06Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩16,750, the stock trades at a trailing P/E ratio of 28.4x. Average trailing P/E is 34x in the Personal Products industry in South Korea. Total returns to shareholders of 71% over the past year.
Valuation Update With 7 Day Price Move • Jun 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩13,300, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 31x in the Personal Products industry in South Korea. Total returns to shareholders of 29% over the past year.
Is New 90 Day High Low • Mar 15New 90-day high: ₩27,750The company is up 40% from a price of ₩19,800 on 15 December 2020. Outperformed the South Korean market which is up 9.0% over the last 90 days. Exceeded the Personal Products industry, which is up 5.0% over the same period.
分析記事 • Mar 10The BIFIDO (KOSDAQ:238200) Share Price Is Up 31% And Shareholders Are Holding OnWe believe investing is smart because history shows that stock markets go higher in the long term. But not every stock...
Is New 90 Day High Low • Dec 16New 90-day high: ₩21,350The company is up 17% from its price of ₩18,250 on 17 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 8.0% over the same period.
分析記事 • Nov 25BIFIDO's (KOSDAQ:238200) Shareholders Are Down 25% On Their SharesPassive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active...
Is New 90 Day High Low • Oct 05New 90-day high: ₩20,100The company is up 3.0% from its price of ₩19,600 on 07 July 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Personal Products industry, which is also up 3.0% over the same period.
